We don't cater to customers in UAE, we only ship internationally.

Sipmax International
  • PAZEQOL-200 Tablets
  • PAZEQOL-200 Tablets

PAZEQOL-200 Tablets

PAZEQOL-200 Tablets PAZEQOL-200 contains Pazopanib, a multi-targeted receptor tyrosine kinase (RTK) inhibitor. It acts by selectively inhibiting vascular endothelial growth factor receptors (VEGFR-1, -2, -3), platelet-derived growth factor receptors (PDGFR-α, -β), and stem cell factor receptor (c-KIT), thereby suppressing tumor angiogenesis, cellular proliferation, and blood vessel growth. It is indicated for the treatment of advanced renal cell carcinoma (RCC) and advanced soft tissue sarcoma (STS) in patients who have received prior chemotherapy.

Read more
WhatsApp Telegram Email
Brand PAZEQOL
Storage Temperature Store below 30°C in a dry place (Protect from light and moisture)
Prescription Needed Yes
Composition Pazopanib Hydrochloride equivalent to Pazopanib
Strength 200 mg
Form Film-coated Tablets (For Oral Use)
Pack Size 30 Tablets
Packaging Bottle containing 30 Tablets
Country of Origin Made In India
Manufacturer Intas Pharmaceuticals Ltd.

PAZEQOL-200 Tablets

PAZEQOL-200 Tablets PAZEQOL-200 contains Pazopanib, a multi-targeted receptor tyrosine kinase (RTK) inhibitor. It acts by selectively inhibiting vascular endothelial growth factor receptors (VEGFR-1, -2, -3), platelet-derived growth factor receptors (PDGFR-α, -β), and stem cell factor receptor (c-KIT), thereby suppressing tumor angiogenesis, cellular proliferation, and blood vessel growth. It is indicated for the treatment of advanced renal cell carcinoma (RCC) and advanced soft tissue sarcoma (STS) in patients who have received prior chemotherapy.

Related Products